胃肠间质瘤靶向药物的治疗药物监测中国专家共识

标题: 胃肠间质瘤靶向药物的治疗药物监测中国专家共识
title: Chinese consensus on therapeutic drug monitoring of targeted drugs for the treatment of gastrointestinal stromal tumors
版本: 原创版
version: Original
分类: 专家共识
classification: Experts consensus
领域: 治疗
field: Treatment
国家和地区: 中国
Country and region: China
指南使用者: 各医疗机构参与胃肠间质瘤治疗与管理的医生、药师、护士、检验人员等
Guide users: Doctors, pharmacists, nurses and laboratory technicians in various medical institutions involved in the treatment and management of gastrointestinal stromal tumors
证据分级方法: GRADE
Evidence grading method:
制定单位: 中国药学会医院药学专业委员会;中国药理学会治疗药物监测研究专业委员会;中国医师协会外科医师分会胃肠道间质瘤诊疗专业委员会;
Formulating unit: Hospital Pharmacy Committee of Chinese Pharmaceutical Association; Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society; Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association;
注册时间: 2021-03-29
Registration time:
注册编号: IPGRP-2021CN075
Registration number:
指南制订的目的: 制定胃肠间质瘤靶向药物的治疗药物监测开展的时机与频率、监测指标与方法、结果解读及临床应用等各个环节的技术规范,指导该类患者个体化治疗和全程化管理
Purpose of the guideline: To formulate the technical specifications of therapeutic drug monitoring for targeted drugs in the treatment of gastrointestinal stromal tumors including timing, frequency and indicators, as well as the interpretation of the results and the clinical application, guiding the individualized therapy and whole-course management of such patients